Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
43
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences
About
Clexio Biosciences is a clinical-stage pharmaceutical company focused on developing novel drugs, small molecules, and drug-device combinations for the treatment of pain, depression, and other central nervous system (CNS) indications. The company's pipeline includes therapies for major depressive disorder, epilepsy, chronic pruritus, neuropathic pain, cluster headache, and Parkinson's disease. Clexio Biosciences is dedicated to developing novel therapies for patients suffering from neurological and psychiatric conditions. One of the company's driving principles is to invent new therapeutic modalities and bring them quickly from an idea to proof of concept and then to full clinical development.
Headcount over time
From 17 (2018-11) to 37 (2026-03) · +20 (+118%) · 17 points · source: Finder history + radar grounding
Q&A
- What is Clexio Biosciences' primary focus?
- Clexio Biosciences is a clinical-stage pharmaceutical company developing CNS therapies for neurological and psychiatric conditions, including major depressive disorder, Parkinson's disease, and pain.
- When was Clexio Biosciences founded?
- Clexio Biosciences was founded in March 2018.
- Where is Clexio Biosciences headquartered?
- Clexio Biosciences is headquartered in Petah Tikva, Israel.
- What is the current employee count for Clexio Biosciences?
- Clexio Biosciences has 11-50 employees.
- Who are the co-founders of Clexio Biosciences?
- The co-founders of Clexio Biosciences are Elisabeth Kogan (Co-founder & CEO) and Menashe Levy (Co-founder & CTO).
- What is Clexio Biosciences' current funding stage?
- Clexio Biosciences is currently in the Pre-Funding stage.
- What sector does Clexio Biosciences primarily operate in?
- Clexio Biosciences primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the product stage of Clexio Biosciences' offerings?
- Clexio Biosciences' products are in the clinical trial stage.
Team · 3
Menashe Levy
Founder · Co-Founder & CTO
Elisabeth Kogan
Founder · CEO & Co-Founder
Elena Kagan
Founder · CDO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
Verified
Tags
pharmaceuticalstherapeuticsparkinsonpatientspain-reliefmental-healthcns-disordersdrug-discoverytreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | clexio.com/ |
|---|---|
| linkedin.com/company/33519910 | |
| YouTube | youtube.com/channel/UCscUGnbNfBXUvBlySrWBekQ |
Identifiers & details
| Founded | 2018-3 |
|---|---|
| Employees (exact) | 43 |
| Offices | Jerusalem |
Radar intelligence
Patents
| EPO | 36 |
|---|
Web history (Wayback)
| Domain | clexio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 10 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515817468 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-03-18 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (1), people (1) |
| Registered address | הקידמה 10 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-31 | דו~ח שנתי |
| 2026-05-04 | עדכון דירקטורים-הסרת דירקטור |